192 related articles for article (PubMed ID: 20878554)
1. Investigation of copy-number variations of C8orf4 in hematological malignancies.
Zhang J; Gao Y; Zhao X; Guan M; Zhang W; Wan J; Yu B
Med Oncol; 2011 Dec; 28 Suppl 1():S647-52. PubMed ID: 20878554
[TBL] [Abstract][Full Text] [Related]
2. Analysis of copy number variations of BS69 in multiple types of hematological malignancies.
Yang H; Zhang C; Zhao X; Wu Q; Fu X; Yu B; Shao Y; Guan M; Zhang W; Wan J; Huang X
Ann Hematol; 2010 Oct; 89(10):959-64. PubMed ID: 20425112
[TBL] [Abstract][Full Text] [Related]
3. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies.
Guan M; Liu L; Zhao X; Wu Q; Yu B; Shao Y; Yang H; Fu X; Wan J; Zhang W
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):50-3. PubMed ID: 21454190
[TBL] [Abstract][Full Text] [Related]
4. The association between the copy-number variations of ZMAT4 and hematological malignancy.
Wan J; Gao Y; Zhao X; Wu Q; Fu X; Shao Y; Yang H; Guan M; Yu B; Zhang W
Hematology; 2011 Jan; 16(1):20-3. PubMed ID: 21269563
[TBL] [Abstract][Full Text] [Related]
5. Examination of copy number variations of CHST9 in multiple types of hematologic malignancies.
Zhao X; Wu Q; Fu X; Yu B; Shao Y; Yang H; Guan M; Huang X; Zhang W; Wan J
Cancer Genet Cytogenet; 2010 Dec; 203(2):176-9. PubMed ID: 21156230
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
7. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies.
Rozenfeld-Granot G; Toren A; Amariglio N; Brok-Simoni F; Rechavi G
Exp Hematol; 2001 Feb; 29(2):228-33. PubMed ID: 11166462
[TBL] [Abstract][Full Text] [Related]
9. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
[TBL] [Abstract][Full Text] [Related]
10. Non-lymphoma hematological malignancies in systemic lupus erythematosus.
Lu M; Bernatsky S; Ramsey-Goldman R; Petri M; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler EM; Yelin E; Bae SC; Wallace DJ; Jacobsen S; Dooley MA; Peschken CA; Alarcón GS; Nived O; Gottesman L; Criswell LA; Sturfelt G; Dreyer L; Lee JL; Clarke AE
Oncology; 2013; 85(4):235-40. PubMed ID: 24107608
[TBL] [Abstract][Full Text] [Related]
11. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
12. Hematological malignancies: role of miRNAs and their in silico aspects.
Omer A; Yadav NK; Singh P; Singh RK
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
14. Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies.
Huang M; Li C; Liang H; Zhou J; Deng J; Liu W
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):661-3. PubMed ID: 17357482
[TBL] [Abstract][Full Text] [Related]
15. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
Grzybowska-Izydorczyk O; Smolewski P
Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
Weldetsadik AT
Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
[TBL] [Abstract][Full Text] [Related]
18. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p16INK4A and p14ARF in haematological malignancies.
Lee YK; Park JY; Kang HJ; Cho HC
Clin Lab Haematol; 2003 Aug; 25(4):233-7. PubMed ID: 12890162
[TBL] [Abstract][Full Text] [Related]
20. The research progress of circular RNAs in hematological malignancies.
Ji T; Chen Q; Tao S; Shi Y; Chen Y; Shen L; Wang C; Yu L
Hematology; 2019 Dec; 24(1):727-731. PubMed ID: 31581903
[No Abstract] [Full Text] [Related]
[Next] [New Search]